Journal articleN Engl J Med2012
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.
- Journal
- N Engl J Med
- Published
- 2 June 2012
- Citations
- 6,365
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Trials 3
- BackgroundNALIRIFOX+Adebrelimab+PULSAR for Advanced Pancreatic Cancer NCT07595172↗
- BackgroundExploratory Platform Trial to Evaluate Immunotherapy Combinations With Chemotherapy for the Treatment of Patients With … NCT04787991↗
- BackgroundSBRT Plus Pembrolizumab and Trametinib for Pancreatic Cancer NCT02704156↗